You searched for "studies"

1629 results found

Medical Medway Fayre 2024

by Ines Lahlou Chettab, Ophthalmologist (Algeria), MCh Ophthalmology Student, Canterbury Christ Church University, UK. Over the past six years, the Institute of Medical Sciences of Canterbury Christ Church University has hosted the Medway Medical Fayre. This event was initiated and...

Predicting ischemic lesion location using perimetry

The authors present a retrospective records review, using the search terms homonymous hemianopia, visual field loss and MRI. Only posterior circulation artery territory ischemic strokes were included. Demographics, stroke details and initial and follow-up with 24-2 SITA Standard perimetry results...

Higher risk of poor functional outcome in the presence of visual deficits post-stroke

The authors present a retrospective case review with the aim of reporting the disability outcomes of individuals 90-days post stroke with and without visual deficits. The Houston Methodist Hospital Outcomes-based Prospective Endpoints in Stroke (HOPES) Registry was used as the...

Diabetes macular oedema in pregnancy self-resolving postpartum

*Equally contributing co-first authors. Diabetic macular oedema (DMO) is a common clinical presentation to ophthalmology clinics. Ample evidence exists for management of DMO in non-pregnant patients. However, there is a paucity of evidence on the optimal management of DMO in...

Mindfulness and cataract surgery experience in ophthalmology doctors in training

Mindfulness can be described as the state in which one is to be fully present in the moment, which draws parallels with surgery. The origins of mindfulness stem from ancient Buddhist traditions, and its utilisation in recent times in the...

Building data infrastructure for eye research in the NHS: Real-world lessons from the Liverpool Eye Data Platform

The Liverpool Eye Data Platform demonstrates how governance-compliant infrastructure can bring together routinely-collected, siloed NHS eye data. Routine care delivered across the NHS generates vast amounts of clinical data within a healthcare system that is uniquely characterised by comprehensive population...

New Treatments in Noninfectious Uveitis

As a specialist registrar training in Aberdeen there were two important lessons I learned which have proved to be invaluable over the years for two very different reasons. The first lesson learned was to never underestimate the wind chill factor...

SightCare Awards 2026 – celebrating excellence in independent optometry

The SightCare Awards 2026 are now open for entries - and this year, they’re bigger, bolder and more prestigious than ever. Set against the stunning backdrop of Edgbaston Stadium, Birmingham, the SightCare Awards return in black-tie style on Sunday 26...

IN FOCUS - Prevention and treatment of blindness worldwide: the story of ‘VISION 2020: The Right to Sight’

The story of blindness and efforts to prevent and treat it cannot be told without going back to the earliest recorded history of blindness. Trachoma was described in ancient Egypt, cataract surgery in India about the fifth century BC and...

Progress in retinal disease management: Highlights of the Retina Day, RCOphth 2025 Annual Congress

The Retina Day meeting at the Royal College of Ophthalmologists (RCOphth) 2025 Annual Congress in Liverpool was held on 22 May 2025. This report highlights 10 selected topics of interest to subspecialists and general ophthalmologists. Decarbonising anti-VEGF clinics (or making...

New Opportunity for Glaucoma Researchers: Apply Now for Glaucoma UK's Open Call Research Award

Glaucoma UK announces the Open Call Research Award 2023, offering up to £50,000 in funding for glaucoma-related research.

Glaucoma UK offers up to £50,000 for the Open Call Research Award 2024

Glaucoma UK accepts applications for the Open Call Research Award 2024, which offers up to £50,000 in funding for glaucoma-related research. This award invites both clinical and non-clinical researchers who aim to enhance our understanding of glaucoma, and improve outcomes for people living with the disease.